Bagalanon, Elenita V.
HRN: 16-44-66 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/19/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/19/2026
05/25/2026
IV
2.25
Q6
Diabetic Foot
Checking Initial Appropriateness
05/19/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/19/2026
05/25/2026
IV
600mg
Q6
Diabetic Foot
Checking Initial Appropriateness
05/19/2026
MUPIROCIN 2%, 15G (TUBE)
05/19/2026
05/25/2026
TOPICAL
2%
Q12
Dia
Checking Initial Appropriateness
05/20/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/20/2026
05/27/2026
IV
500mg
Q8H
DM FOOT
Checking Final Appropriateness
05/25/2026
CEFTRIAXONE 1G (VIAL)
05/25/2026
06/01/2026
IVTT
2g
OD
NONHEALING WOUND
Checking Initial Appropriateness
05/25/2026
MUPIROCIN 2%, 15G (TUBE)
05/25/2026
06/01/2026
TOPICAL
Apply On Affected Are
BID
Nonhealing Wound
Checking Initial Appropriateness